Tuesday 21 July 2026

Bio-Tech

C-CAMP receives CSR support from Cytiva to foster early-stage innovations in India
30th May, 2023

C-CAMP receives CSR support from Cytiva to foster early-stage innovations in India

Bengaluru-based Centre for Cellular and Molecular Platforms (C-CAMP) has re...

FDA Approves Lexicon's INPEFA (sotagliflozin) for Heart Failure
29th May, 2023

FDA Approves Lexicon's INPEFA (sotagliflozin) for Heart Failure

Lexicon Pharmaceuticals, Inc. today announced that the U.S. Food and Drug A...

TScan Therapeutics Successfully Prices $140 Million Public Offering
29th May, 2023

TScan Therapeutics Successfully Prices $140 Million Public Offering

TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company focuse...

Cullinan Oncology to Present First Monotherapy Clinical Data for CLN-619, a Novel Anti-MICA/B Antibody, at ASCO 2023
26th May, 2023

Cullinan Oncology to Present First Monotherapy Clinical Data for CLN-619, a Novel Anti-MICA/B Antibody, at ASCO 2023

Cullinan Oncology, Inc., a biopharmaceutical company focused on modality-ag...

TechInvention & Reagent IVD Resources to develop comprehensive range of diagnostics
26th May, 2023

TechInvention & Reagent IVD Resources to develop comprehensive range of diagnostics

TechInvention Lifecare, a Mumbai-based biotech startup, has entered into a ...

ZAGENO Secures $33M Funding to Revolutionize Life Science Research Procurement
26th May, 2023

ZAGENO Secures $33M Funding to Revolutionize Life Science Research Procurement

ZAGENO, the leading online marketplace for life science research products, ...

Panavance Therapeutics to Present at BIO International Convention
25th May, 2023

Panavance Therapeutics to Present at BIO International Convention

Panavance Therapeutics Inc. is a privately-held, clinical-stage pharmaceuti...

Pluton Biosciences Raises $16.5M Series A to Harness Microbes for Climate Change Combat
25th May, 2023

Pluton Biosciences Raises $16.5M Series A to Harness Microbes for Climate Change Combat

Pluton Biosciences, a startup leveraging the power of microbes to create co...

Telesis Bio Announced as Featured Presenter at SynBioBeta 2023
24th May, 2023

Telesis Bio Announced as Featured Presenter at SynBioBeta 2023

Telesis Bio Inc., a leader in automated multi-omic and synthetic biology so...

Folia Health Launches Canopy Series: User-Led Research Program
24th May, 2023

Folia Health Launches Canopy Series: User-Led Research Program

Today, Folia Health announced a first-of-its-kind observational research in...

Phathom Pharmaceuticals Resubmits New Drug Application for Erosive GERD to FDA
24th May, 2023

Phathom Pharmaceuticals Resubmits New Drug Application for Erosive GERD to FDA

Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on devel...

Valo Therapeutics Begins First Patient Dosing of PeptiCRAd-1, Advancing Immuno-oncology Innovation
23rd May, 2023

Valo Therapeutics Begins First Patient Dosing of PeptiCRAd-1, Advancing Immuno-oncology Innovation

Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunother...

Telesis Bio Announces First Commercial Shipment of BioXp Select DNA Cloning Kit
23rd May, 2023

Telesis Bio Announces First Commercial Shipment of BioXp Select DNA Cloning Kit

Telesis Bio Inc., a leader in automated multi-omic and synthetic biology so...

NMD Pharma launches Phase I study of NMD1343 for safety and pharmacokinetics
23rd May, 2023

NMD Pharma launches Phase I study of NMD1343 for safety and pharmacokinetics

NMD Pharma A/S, a clinical-stage biotech company developing first-in-class,...

NeoDx Biotech Labs unveils 7 real time PCR based kits for detecting infectious diseases
23rd May, 2023

NeoDx Biotech Labs unveils 7 real time PCR based kits for detecting infectious diseases

NeoDx Biotech Labs, a Bengaluru-based startup incubated at Bangalore Bioinn...

PharmEnable Secures $7.5M Funding, Led by MP Healthcare, for Novel Cancer and Neurological Disease Therapies
22nd May, 2023

PharmEnable Secures $7.5M Funding, Led by MP Healthcare, for Novel Cancer and Neurological Disease Therapies

PharmEnable, a drug discovery company focused on chemical novelty, diversit...

FDA Approves Krystal Biotech's Redosable Gene Therapy VYJUVEK for Dystrophic Epidermolysis Bullosa
22nd May, 2023

FDA Approves Krystal Biotech's Redosable Gene Therapy VYJUVEK for Dystrophic Epidermolysis Bullosa

Krystal Biotech, Inc., a biotechnology company focused on developing and co...

Mount Sinai Enhances Cancer Care with $4 Million Expansion, Including Infusion Center
22nd May, 2023

Mount Sinai Enhances Cancer Care with $4 Million Expansion, Including Infusion Center

The Mount Sinai Health System today held a grand opening of the expansion o...